Medgend Icon

Ledgend of Medicine







discontinued


Vimovo FDA Approved Drugs

NAPROXEN AND ESOMEPRAZOLE MAGNESIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O : NaproxenC14H14O3]
RX
-
eq 20mg base : 375mg (oral tablet, delayed release)
eq 20mg base : 500mg (oral tablet, delayed release)
Dr Reddys Labs LtdSep 27, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VIMOVO [Esomeprazole Magnesium2C17H18N3O3SMg3H2O : NaproxenC14H14O3]
RX
-
eq 20mg base : 375mg (oral tablet, delayed release)
eq 20mg base : 500mg (oral tablet, delayed release)
Horizon Pharma UsaApr 30, 2010
  • Relief of signs and symptoms of arthritis and risk-reduction of nsaid-associated gastric ulcer.
  • Risk-reduction of nsaid gastric ulcer in patients requiring chronic nsaid treatment.
  • Risk-reduction of nsaid-associated gastric ulcer in patients requiring nsaid treatment.
  • Risk-reduction of nsaid-associated gastric ulcer.
  • Risk-reduction of nsaid-associated gastric ulcers in patients also taking low dose aspirin.
efficacy
3.5  (2)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.